SC
WVE icon

Savant Capital’s Wave Life Sciences WVE Stock Holding History

Savant Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Buy
52,275
+36,324
+228% +$241K ﹤0.01% 1445
2026
Q1 		$116K Buy
15,951
+3,000
+23% +$39.1K ﹤0.01% 1460
2025
Q4 		$220K Buy
+12,951
New +$132K ﹤0.01% 1240

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Savant Capital's WVE Position: Q2 2026 in Review

Savant Capital increased its Wave Life Sciences (WVE) stake by 228% in Q2 2026, buying an estimated $241K and bringing the position to 52,275 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

Savant Capital first reported a position in WVE in Q4 2025 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Savant Capital held 52,275 shares of Wave Life Sciences worth $327K as of Q2 2026.
  • Savant Capital bought 36,324 Wave Life Sciences shares in Q2 2026, an estimated $241K.
  • Wave Life Sciences made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1445 holding.
  • Savant Capital first reported a position in Wave Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.